Clinical study of snake antipruritic pills in the treatment of chronic spontaneous urticaria

A Clinical Study on the Efficacy and Safety of Sanhuang Xiaozhen Decoction in the Treatment of Chronic Spontaneous Urticaria (Wind-Heat Syndrome)

首次发布于 2026 年 7 月 6 日

Dupilumab in Chronic Spontaneous Urticaria

计划入组 72 人 · 首次发布于 2018 年 11 月 21 日

Chronic Spontaneous Urticaria(Alys)

Bilastine(Blexten)

C₂₈H₃₇N₃O₃ · Rx

Ligelizumab

Kineta Chronic Pain LLC

United States

PEGBIO CO-B

HCW Biologics

United States

FDA Approves Dupilumab for Chronic Spontaneous Urticaria, Expanding Treatment Options

European Commission Approves Dupixent as First-Line Targeted Therapy for Chronic Spontaneous Urticaria

RAPT Therapeutics Prepares to Release Phase 2 Data for RPT904 in Chronic Spontaneous Urticaria